Amunix

Amunix is a biotechnology company that develops advanced protein-based therapeutics, primarily focusing on targeted cancer treatments. They engineer specialized proteins called antibodies and other biologics to better recognize and attack cancer cells while minimizing harm to normal cells. Using innovative technology, Amunix aims to create more effective and safer medicines that improve patient outcomes. Their work involves designing proteins at a molecular level to enhance specificity, stability, and activity, contributing to personalized and precise medical interventions in oncology.